Literature DB >> 17116352

No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjects.

Akihito Suzuki1, Takashi Fukasawa, Hiroaki Shiraishi, Genki Ishii, Shingo Oshino, Toshiaki Aoshima, Koichi Otani.   

Abstract

It has been suggested that the central serotonergic activity is implicated in personality traits. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin synthesis. In the present study, the association between the TPH A218C polymorphism and personality traits assessed by the Temperament and Character Inventory (TCI) was examined in 345 Japanese healthy subjects. The TPH A218C polymorphism was determined by a PCR-RFLP method. There were no significant differences in the seven dimension scores of TCI among the A/A, A/C, and C/C genotype groups by the one-way ANOVA. There was a significant negative correlation between age and the NS scores. Females showed significantly higher scores of HA, RD, and ST, and significantly lower scores of SD than males. The multiple regression analysis using age, gender, and the TPH genotype as independent variables also showed no significant association between any dimension score and the genotype. The present study thus suggests that the TPH A218C polymorphism does not affect personality traits in Japanese healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116352     DOI: 10.1016/j.pnpbp.2006.10.003

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Brain Modules, Personality Layers, Planes of Being, Spiral Structures, and the Equally Implausible Distinction between TCI-R "Temperament" and "Character" Scales: A Reply to Cloninger.

Authors:  Richard F Farmer; Lewis R Goldberg
Journal:  Psychol Assess       Date:  2008-09

2.  TPH1 A218C polymorphism and temperament in major depression.

Authors:  Kadri Andre; Olli Kampman; Merja Viikki; Ari Illi; Eija Setälä-Soikkeli; Outi Poutanen; Nina Mononen; Esa Leinonen; Terho Lehtimäki
Journal:  BMC Psychiatry       Date:  2013-04-18       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.